International Journal of Gynecological Cancer
Publisher: Elsevier · ISSN 1048-891X · 88 articles
- Actionable biomarker co-expression in advanced ovarian cancer: folate receptor alpha expression and related markers
- Early death and early relapse in advanced ovarian cancer: distinct clinical phenotypes in the International SUROVA cohort
- Exploring the association between homologous recombination status, KELIM, and resectability in high-grade serous ovarian cancer
- Incidence and early prediction of post-operative pancreatic fistula after splenectomy in ovarian cancer cytoreduction within an enhanced recovery after surgery pathway: the ERASPLEEN study
- Hyperthermic intraperitoneal chemotherapy is associated with improved overall survival in advanced non–high-grade epithelial ovarian, fallopian tube, and primary peritoneal carcinoma
- Risk-reducing gynecologic surgery in non-BRCA cancer predisposition mutations: a multi-institutional study
- Role of surgery in stage IV high-grade serous ovarian cancer: a French population-based multi-center study using Epidemiological Strategy and Medical Economics ovarian cancer database
- Retrospective evaluation of minimally invasive surgical strategies in ovarian neoplasms (REMISSION study): oncological outcomes
- Artificial intelligence for the assessment of peritoneal carcinomatosis during diagnostic laparoscopy for advanced ovarian cancer
- Artificial intelligence-assisted triage of cervical biopsies using the low-cost, 3D-printed OpenFlexure Microscope: a paired comparative feasibility study
- Not all artificial intelligence large language models are created equal: heterogeneous performance in therapeutic decision-making for recurrent epithelial ovarian cancer
- Gender inequalities in sexual health assessment after pelvic radiotherapy
- Follow-up after fertility-sparing surgery for cervical cancer: should human papillomavirus testing be used routinely? A narrative review
- Arterial embolization for hemorrhage control in gynecologic malignancies: a narrative review of current evidence and unresolved questions
- Treatment strategies for oligometastatic and oligorecurrent epithelial ovarian cancer: a narrative review
- Dexamethasone-associated hyperglycemia during chemotherapy in endometrial and ovarian cancer: a retrospective study
- Comparison of sentinel lymph node mapping with comprehensive lymphadenectomy in p53-mutated endometrial cancer: a prospective, multi-center, non-inferiority, open-label, de-escalation, randomized, controlled trial (Study Protocol - SENTIMETREP53)
- Decision-making in high-grade endometrial carcinoma when fertility preservation is not feasible
- Early-career voices in International Gynecologic Cancer Society: global perspectives on needs for members
- First robotic radical trachelectomy for cervical cancer using the Hugo RAS platform
- Minimally invasive lateral pelvic sidewall resection for nodal recurrence of high-grade endometrioid endometrial carcinoma
- Right subphrenic peritonectomy procedure without initial liver mobilization to facilitate complete macroscopic resection of tumor in advanced tubo-ovarian carcinoma
- Invasive complete hydatidiform mole
- Torsion of a borderline ovarian tumor in a pregnancy
- Beyond the number of cycles: lessons from the CHRONO trial in advanced ovarian cancer
- Rethinking adjuvant treatment intensification in early-stage cervical cancer after radical surgery
- #Jump4June: an opportunity to revisit the evaluation of post-menopausal bleeding
- Lymphovascular space invasion in cervical cancer: beyond the binary
- Personalized circulating tumor DNA–based minimal residual disease assessment for optimizing interval debulking surgery timing in advanced ovarian cancer: toward precision surgical oncology
- Is conization with lymph node dissection safe for International Federation of Gynecology and Obstetrics 2018 stage IB1 cervical cancer measuring 1 to 2 cm?